Case Study: A TBI Patient, a Complex Allergy Profile, and a Medication Nobody Could Source

James Wong — Founder & Pharmacist, LienScripts | March 3, 2025 | 7 min read

A law firm reached out in desperation: their TBI client had been prescribed Metanx FC specifically because of a complex allergy profile — and no pharmacy could or would source it. Here's how LienScripts stepped in, what the non-formulary exception process looked like, and why we committed to care that outlasts the case.

Case Study: A TBI Patient, a Complex Allergy Profile, and a Medication Nobody Could Source

Details have been modified to protect patient privacy. This is a composite account based on real scenarios encountered in our practice.

The call came from a paralegal at a mid-sized personal injury firm. Their client — a woman in her late thirties who had sustained a traumatic brain injury in a rear-end collision — had been prescribed Metanx FC by her neurologist. The prescription had been sitting unfilled for three weeks.

Two pharmacies had already turned them away. One didn't carry it. The other said they'd never heard of it and couldn't order it. The paralegal had called four more pharmacies. Nothing. They were starting to lose hope that the medication could be filled at all.

[!KEY] A TBI patient in her late thirties with a complex allergy profile had a Metanx FC prescription sitting unfilled for three weeks after six pharmacies refused to source it — a pharmacy lien non-formulary exception had the medication dispensed within two business days at zero upfront cost.

Patient Profile

The allergy profile is what made this case unusual. The patient had documented sensitivities to FD&C dyes, shellfish-derived ingredients, and titanium dioxide — a white pigment used as an inactive excipient in the majority of pharmaceutical capsules. Her neurologist had specifically prescribed Metanx FC because it is the only commercially available B-vitamin therapeutic formulation that is:

• Dye-free
• Titanium dioxide-free
• Free from all 9 FDA major allergens (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy, and sesame)
• Preservative-free, vegan, and non-GMO verified

A generic B-complex was not clinically interchangeable. The prescriber had documented this in a medical necessity letter. The medication wasn't a brand preference — it was the only formulation this patient could safely take.

[!KEY] When a prescriber specifies Metanx FC because of documented excipient allergies — dyes, titanium dioxide, shellfish-derived ingredients — that formulation choice is clinical necessity, not brand preference, and the medical necessity documentation protects both the lien and the case at settlement.

The Clinical Picture: Why Metanx for TBI?

Traumatic brain injury is commonly understood as a central nervous system injury — damage to the brain itself. What is less appreciated is that TBI frequently produces peripheral neurological consequences as well. Diffuse axonal injury and secondary neuroinflammation can disrupt the vasa nervorum (the tiny blood vessels supplying peripheral nerves), leading to peripheral neuropathy that persists long after the acute injury resolves.

For this patient, the neuropathy manifested as bilateral burning sensations in the hands and feet, with pronounced allodynia — pain triggered by stimulation that would not normally be painful, like light touch or a change in temperature.

The neurologist's choice of Metanx was grounded in the mechanism of its active ingredients. Methylcobalamin — the neurologically active form of B12 — has documented evidence for nerve repair, myelin regeneration, and neuroprotection following traumatic injury. L-methylfolate and pyridoxal-5'-phosphate address homocysteine accumulation and endothelial dysfunction in the nerve vasculature, both of which are disrupted after trauma.

The prescription was clinically sound. The access problem was not.

The Problem: Metanx in a Coverage Gap

Metanx is a prescription medical food — a specific FDA regulatory category that requires a physician's prescription but is not classified as a pharmaceutical drug. That classification is exactly what creates the coverage gap.

Insurance formularies are built around FDA-approved drugs. Medicare Part D does not cover medical foods. Most private insurers follow the same logic. There is no formulary exception pathway for Metanx because there is no coverage category for it to be excepted into.

The pharmacy network problem is separate but related. Because Metanx is prescribed infrequently at most retail pharmacies, many chains simply don't maintain it in their inventory or have no ordering relationship with Alfasigma USA. Patients who need it are often told the medication doesn't exist — when in fact it does, just not on that pharmacy's radar.

This patient had the prescription. She had the medical necessity documentation. She had a lawyer working her case. She just couldn't get the medication.

What LienScripts Did

When the paralegal reached us, the first conversation was educational. Most law firms encountering Metanx for the first time don't know what a prescription medical food is — and don't know that a pharmacy lien's formulary isn't the same as an insurance formulary.

Step 1: Explaining the non-formulary exception process. LienScripts maintains a standard formulary built around the most common medications prescribed in personal injury care. Metanx is not on that standard list — it's too infrequently prescribed in PI contexts to warrant routine inclusion. But the standard formulary is a workflow tool, not a ceiling.

For clinically necessary medications outside the standard formulary, LienScripts offers a non-formulary exception: the attorney of record acknowledges in writing that the medication is part of the lien agreement, and LienScripts sources and covers it from there. The physician's medical necessity documentation becomes part of the patient's file.

The attorney understood immediately. The acknowledgment was straightforward — a written confirmation that Metanx FC was included in the lien agreement alongside the patient's standard medications.

Step 2: Sourcing and coverage confirmation. Within two business days of receiving the attorney acknowledgment and the medical necessity documentation, LienScripts confirmed coverage and arranged for the medication to be dispensed. The patient received Metanx FC at zero upfront cost — the same lien structure that applied to her other prescriptions.

Step 3: Ongoing management. Metanx was maintained as an active medication throughout the litigation period. Each refill was documented in the pharmacy file. The clinical narrative — developed by our pharmacist team for the POGOS report — included the neurologist's rationale for the specific formulation, the documented allergy profile precluding alternatives, and the ongoing medical necessity of the therapy.

[!KEY] The non-formulary exception process for a pharmacy lien is a simple written acknowledgment from the attorney — five minutes of paperwork that gives a TBI patient access to the exact medication their neurologist prescribed rather than an allergenic substitute no retail pharmacy would stock anyway.

The Extra Mile: Planning for Life After Settlement

This is where most pharmacy lien programs stop. The case is active, the medication is covered, the lien gets repaid at settlement. Done.

We don't think that's good enough for a patient who is going to need this medication for years.

TBI-related peripheral neuropathy doesn't resolve at settlement. The neurologist had indicated that long-term management was likely — potentially indefinitely. For a patient in her late thirties, that could mean decades of ongoing Metanx fills at out-of-pocket cost once the lien program is no longer involved.

"The settlement closed the legal case — it didn't close the door on her care."

Before the case closed, our team worked to connect the patient with resources for post-settlement continuity:

• Alfasigma patient assistance programs — the manufacturer offers assistance for qualifying patients who meet income thresholds or lack insurance coverage
• GoodRx and cash-pay discount programs — which, combined with a pharmacy that carries the medication, can meaningfully reduce the monthly cost
• Specialty pharmacy options — independent pharmacies that routinely stock Metanx and have pricing structures more favorable than retail chains

The settlement closed the legal case. It didn't close the door on her care.

Key Takeaways for Attorneys

1. You don't have to limit your client's treatment to whatever a pharmacy carries off the shelf. If a prescribing physician has specified a particular medication — especially with documented medical necessity — a pharmacy lien program with a non-formulary exception process can often cover it. The question to ask is not "is this on the standard list?" but "is this medically appropriate and prescribed?"

[!TIP] When a prescriber specifies a particular formulation due to allergy restrictions, document the medical necessity explicitly in the chart notes and request a non-formulary exception from your pharmacy lien provider — formulation specificity driven by allergy is clinical necessity, not brand preference.

2. Formulation specificity is clinical necessity — document it as such. When a patient's allergy profile rules out standard alternatives, the prescriber's choice of a specific formulation is not a brand preference. It is a clinical necessity. Make sure the medical necessity letter explicitly documents the allergy profile and the reason the specific formulation was chosen. This documentation protects the claim at settlement.

3. The non-formulary process is not a complication — it's a written confirmation. The attorney acknowledgment required for a non-formulary exception is a simple written confirmation that the medication is part of the lien agreement. It does not create additional liability. It does not complicate the case. It takes five minutes and gives your client access to the medication they need.

Key Takeaways for Patients

1. If your doctor prescribed a specific medication for a documented reason, that specificity matters. Don't let a pharmacist or an insurance denial letter convince you to substitute a cheaper alternative when your prescriber documented why the specific product was medically necessary. That documentation is important both for your health and for your case.

2. A pharmacy lien can cover medications that insurance won't touch. Prescription medical foods like Metanx, compounded medications, and other non-standard therapies can often be covered under a pharmacy lien when insurance refuses. The lien framework operates outside insurance formularies entirely.

3. Your care doesn't have to end when your settlement check arrives. Ask your pharmacy lien provider about post-settlement resources before the case closes. Manufacturer assistance programs, GoodRx pricing, and cash-pay specialty pharmacy options can bridge the gap between settlement and long-term affordability.

Related Resources

• What Is Metanx? A Prescription Medical Food for Nerve Damage
• Non-Formulary Medications in PI Cases: A Guide for Attorneys
• TBI and Lien-Based Medications
• Prior Authorization Workarounds for Personal Injury Patients
• For Attorneys: How LienScripts Works
• Pharmacy Services for Personal Injury Clients: How It Works